PHARMACOLOGICAL AND PHARMACOKINETIC JUSTIFICATION FOR THE DEVELOPMENT OF AN INTRANASAL GEL WITH CLONIDINE HYDROCHLORIDE

2026

Closed access Metadata (CSL-JSON)
DOI 10.53511/pharmkaz.2026.3.7
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Arterial hypertension remains an urgent medical and social problem requiring the development of fastacting and effective dosage forms. Clonidine hydrochloride is a promising active pharmaceutical substance due to its pronounced central antihypertensive activity and favorable physico-chemical characteristics.